MiraVista Aims to Improve Testing for Misdiagnosed Infections

Posted: Updated:
The company expects to expand even more quickly as it develops a new rapid test for histoplasmosis. The company expects to expand even more quickly as it develops a new rapid test for histoplasmosis.

Histoplasmosis isn’t top of mind for most people, but if you’re a Hoosier, it’s likely that you’ve had it. MiraVista Diagnostics Medical Director and President Dr. Lawrence Joseph Wheat says about half of people living in Indiana have had histoplasmosis, an infection caused by a fungus that can be found in soil containing large amounts of bird or bat droppings. Building on nearly two decades of infectious disease testing, the Indianapolis-based company is on the cusp of major growth that could make detecting fungal infections faster and more efficient.

The Centers for Disease Control and Prevention (CDC) says people can get histoplasmosis after breathing in the microscopic fungal spores from the air. Although most who breathe in the spores don’t get sick, Wheat says the infection can be dangerous for people with weakened immune systems. It’s most common in the Midwest, and Wheat says it’s likely about 90 percent of people living in Tennessee have had the infection.

“[Diagnostics] are really important in areas where these fungal infections are seen,” says Wheat. “If these tests aren’t available, there are [immunocompromised] patients who would die without treatment, or would be much sicker by the time they’re diagnosed and have a more difficult response to treatment.”

Wheat says MiraVista performs the bulk of fungal infection testing for the U.S. Humans comprise about two-thirds of its testing, but the company also tests veterinary patients. Most samples arrive at the Indianapolis facility from reference labs and academic medical centers throughout the country.

Wheat developed the proprietary test in the late 1980s as an infectious disease specialist at the Indiana University School of Medicine. He left the university in 2002 to start MiraVista, which began with just five employees, but has now grown to 50.

The company is anticipating to expand even more quickly as it develops a new kind of test for histoplasmosis. Unlike the enzyme assay that requires high-tech equipment in MiraVista’s clinical lab, Wheat says the new diagnostic “is a rapid test, like a pregnancy test that can be performed in the local lab on small numbers of samples.”

A trial testing MiraVista’s rapid diagnostic is underway in Latin America, with a second scheduled to start soon. Wheat says the standard method in Latin America to detect histoplasmosis is to examine a tissue sample under a microscope, which can be a barrier for easy diagnosis.

“There’s probably more histoplasmosis in Latin America than the U.S.,” says Wheat. “It’s common in most Latin American countries, so a rapid test will be very important there. We’re going to put a lot of emphasis on [the trials] in the next two years to try to make [the rapid test] available there.”

While most of its work focuses on histoplasmosis, MiraVista also tests for blastomycosis and coccidioidomycosis, more commonly known as Valley fever, which can be severe even in healthy people. The National Institutes of Health awarded a grant to MiraVista to also develop a rapid test for Valley fever.

The CDC says about 10,000 cases of Valley fever are reported each year, mostly in the Southwest, but tens of thousands more likely occur and are misdiagnosed, because many patients are not tested for the condition.

Wheat says the company’s growth over the last two years has enabled it to work on demanding projects, such as expanding to Latin America. He expects the number of employees at MiraVista to double—reaching 100—in the next two years as it implements new tests and further develops diagnostics in its pipeline.

“We are doubling the size of our building and recruiting more scientists who can bring new ideas to research. We have facilities here to manufacture kits, develop kits and add new services,” says Wheat. “Our veterinarian practice is probably only a quarter of what it could be, once we implement better marketing. We have a lot going on this year we think will take us to another level.”

Wheat says missing a diagnosis for fungal infections such as histoplasmosis or Valley fever can be extremely dangerous, especially for patients with weakened immune systems.
Wheat says Americans’ awareness of fungal infections is relatively low, but health officials in the Southwest are trying to educate the public about coccidioidomycosis (Valley fever).
  • Perspectives

    • Indiana's Regrettable Struggle to Pass Hate Crime Legislation

      It shouldn’t be this hard. The Senate’s Public Policy Committee voted 9-1 in favor of SB-12 this week, a bill that would have codified (as written) hate crime bias to include protections for race, religion, color, sex, gender identity, disability, national origin, ancestry, sexual orientation, and age. SB-12 then made its way to the full Senate. Preceded by a lengthy deliberation by the Senate’s Republican caucus, the Senate voted 33-16 in favor of a watered-down...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Scotty McCreery will perform at Elkhart’s Lerner Theater on Idea Week’s Elkhart Day.

      Country Singer Joins Idea Week Line Up

      The University of Notre Dame has announced a new act joining this year's Idea Week innovation festival. The award-winning country singer got his start by winning “American Idol” in 2011. 

    • Indiana's Regrettable Struggle to Pass Hate Crime Legislation

      It shouldn’t be this hard. The Senate’s Public Policy Committee voted 9-1 in favor of SB-12 this week, a bill that would have codified (as written) hate crime bias to include protections for race, religion, color, sex, gender identity, disability, national origin, ancestry, sexual orientation, and age. SB-12 then made its way to the full Senate. Preceded by a lengthy deliberation by the Senate’s Republican caucus, the Senate voted 33-16 in favor of a watered-down...

    • New Leader Aims to Expose International School's Assets

      The new head of school at the International School of Indiana says she wants to build on 25 years of growth. Elizabeth Head, who became the school’s first female leader last month, says the school’s reputation for contributing to the workforce and attracting talent from around the world excited her about the job. She says the ISI is the only school of its kind not just in Indiana, but throughout the Midwest. In an interview on Inside INdiana Business with Gerry Dick...

    • Indiana is one of five states without a specific hate crimes law.

      Senate Passes Amended Hate Crimes Bill

      The Indiana Senate has passed a hate crimes bill, which includes a controversial amendment approved Wednesday in committee. The bill, which no longer includes a list of targeted groups, was approved by a vote of 39-10. The bill now includes a line stating criminal sentences can be lengthened for reasons "including bias."

    • Indiana Rural School Clinic Network Expands to Pekin

      East Washington School Corp. has announced that East Washington Elementary School is now a participant in the Indiana Rural School Clinic Network. Supported by Ascension/St. Vincent Salem, the school now has a telehealth clinic available to its students and staff.